Literature DB >> 16412045

Regulation of local and metastatic host-mediated anti-tumour mechanisms by L-selectin and intercellular adhesion molecule-1.

M Yamada1, K Yanaba, M Hasegawa, Y Matsushita, M Horikawa, K Komura, T Matsushita, A Kawasuji, T Fujita, K Takehara, D A Steeber, T F Tedder, S Sato.   

Abstract

Malignant melanoma is often accompanied by a host response of inflammatory cell infiltration that is highly regulated by multiple adhesion molecules. To assess the role of adhesion molecules, including L-selectin and intercellular adhesion molecule-1 (ICAM-1), in this process, subcutaneous primary growth and metastasis to the lung of B16 melanoma cells not expressing L-selectin, ICAM-1 or their ligands were examined in mice lacking L-selectin, ICAM-1 or both. Primary subcutaneous growth of B16 melanoma was augmented by loss of L-selectin, ICAM-1 or both, while pulmonary metastasis was enhanced by the loss of L-selectin or combined loss of L-selectin and ICAM-1. In both situations, the combined loss of L-selectin and ICAM-1 exhibited the greatest effect. This enhancement was associated generally with a reduced accumulation of natural killer (NK) cells, CD4+ T cells and CD8+ T cells and also with a diminished release of interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha but not interleukin (IL)-6. Cytotoxicity against melanoma was not defective by the absence of ICAM-1, L-selectin or both, suggesting that the enhancement of tumour growth and metastasis caused by the loss of adhesion molecules results from an impaired migration of effector cells into the tissue rather than from a suppression of the cytotoxic response. The results indicate that L-selectin and ICAM-1 contribute co-operatively to the anti-tumour reaction by regulating lymphocyte infiltration to the tumour.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412045      PMCID: PMC1809598          DOI: 10.1111/j.1365-2249.2005.02989.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis.

Authors:  Yasuhito Hamaguchi; Yoriko Nishizawa; Masahide Yasui; Minoru Hasegawa; Yuko Kaburagi; Kazuhiro Komura; Tetsuya Nagaoka; Eriko Saito; Yuka Shimada; Kazuhiko Takehara; Takafumi Kadono; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression.

Authors:  Yuko Kaburagi; Minoru Hasegawa; Tetsuya Nagaoka; Yuka Shimada; Yasuhito Hamaguchi; Kazuhiro Komura; Eriko Saito; Koichi Yanaba; Kazuhiko Takehara; Takafumi Kadono; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

Review 3.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

4.  Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression.

Authors:  T Nagaoka; Y Kaburagi; Y Hamaguchi; M Hasegawa; K Takehara; D A Steeber; T F Tedder; S Sato
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.

Authors:  R Benamouzig; H Yoon; J Little; A Martin; D Couturier; J Deyra; T Coste; S Chaussade
Journal:  Eur J Cancer Prev       Date:  2001-08       Impact factor: 2.497

6.  A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

Authors:  J Meijerink; C Mandigers; L van de Locht; E Tönnissen; F Goodsaid; J Raemaekers
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

7.  Pretreatment with PKC inhibitor triggers TNF-alpha induced apoptosis in TNF-alpha-resistant B16 melanoma BL6 cells.

Authors:  Shozo Nishida; Shohei Yoshioka; Saori Kinoshita-Kimoto; Michiyo Kotani; Masanobu Tsubaki; Yoshiki Fujii; Takanori T Tomura; Kiyohiro Irimajiri
Journal:  Life Sci       Date:  2003-12-26       Impact factor: 5.037

8.  Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.

Authors:  Anita E M Dirkx; Mirjam G A Oude Egbrink; Marijke J E Kuijpers; Sandra T van der Niet; Viviane V T Heijnen; Jessica C A Bouma-ter Steege; John Wagstaff; Arjan W Griffioen
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

9.  Transfection of macrophage inflammatory protein 1 alpha into B16 F10 melanoma cells inhibits growth of pulmonary metastases but not subcutaneous tumors.

Authors:  Hendrik W van Deventer; Jonathon S Serody; Karen P McKinnon; Casey Clements; W June Brickey; Jenny P-Y Ting
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

Review 10.  The role of chemokines in melanoma tumor growth and metastasis.

Authors:  Aimee S Payne; Lynn A Cornelius
Journal:  J Invest Dermatol       Date:  2002-06       Impact factor: 8.551

View more
  19 in total

Review 1.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.

Authors:  Vinoth Sundar Rajan; Valérie M Laurent; Claude Verdier; Alain Duperray
Journal:  Biophys J       Date:  2017-03-28       Impact factor: 4.033

3.  Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils.

Authors:  Pu Zhang; Tugba Ozdemir; Chin-Ying Chung; Gavin P Robertson; Cheng Dong
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

4.  Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell Entry.

Authors:  Amber N Woods; Ashley L Wilson; Nithya Srivinisan; Jianhao Zeng; Arun B Dutta; J David Peske; Eric F Tewalt; Randal K Gregg; Andrew R Ferguson; Victor H Engelhard
Journal:  Cancer Immunol Res       Date:  2017-11-02       Impact factor: 11.151

Review 5.  Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

Authors:  Russell R Braeuer; Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Menashe Bar-Eli
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

6.  Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29).

Authors:  M Gallicchio; A C Rosa; C Dianzani; L Brucato; E Benetti; M Collino; R Fantozzi
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

7.  Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

Authors:  C Dianzani; L Brucato; M Gallicchio; A C Rosa; M Collino; R Fantozzi
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

8.  Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.

Authors:  Erica M Hanson; Virginia K Clements; Pratima Sinha; Dan Ilkovitch; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

9.  After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.

Authors:  Jian Kong; Lingqun Kong; Jinge Kong; Shan Ke; Jun Gao; Xuemei Ding; Lemin Zheng; Huichuan Sun; Wenbing Sun
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

10.  Natural killer cells require selectins for suppression of subcutaneous tumors.

Authors:  Olga Sobolev; Patrick Stern; Adam Lacy-Hulbert; Richard O Hynes
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.